|
English
|
正體中文
|
简体中文
|
2850591
|
|
???header.visitor??? :
44666780
???header.onlineuser??? :
1221
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"ford her"???jsp.browse.items-by-author.description???
Showing items 1-1 of 1 (1 Page(s) Totally) 1 View [10|25|50] records per page
| 國家衛生研究院 |
2024-09 |
Trastuzumab deruxtecan (T-DXd) monotherapy and combinations in patients (pts) with advanced/metastatic HER2-positive (HER2+) esophageal, gastric or gastroesophageal junction adenocarcinoma (GEJA): DESTINY-Gastric03 (DG-03)
|
Janjigian, YY;van Laarhoven, HWM;Rha, SY;Kozlov, V;Oh, DY;Gravina, A;Rapatoni, L;Shoji, H;Hofheinz, RD;Chen, LT;Ford, HER;Chenard-Poirier, M;Raoufmoghaddam, S;Lloyd, C;Zhang, C;Mateo, C;Lee, J |
Showing items 1-1 of 1 (1 Page(s) Totally) 1 View [10|25|50] records per page
|